A decade after the discovery of CALR, the results are the first for a possible therapy for CALR-mutated MPNs to reach the ...

The findings show that increases in serum glial fibrillary acidic protein throughout B-cell depletion therapy are associated ...

High cumulative doses of epipodophyllotoxins were associated with the highest risk for survivors of childhood cancer of ...

Despite found associations, due to small sample sizes the researchers suggest readers interpret their findings with caution.

With ponatinib (Iclusig) receiving an accelerated approval from the FDA earlier this year for the treatment of Philadelphia ...

November is Diabetic Eye Disease Awareness Month. Diabetes is the leading cause of preventable blindness in the US. Here is a ...

Matias Sanchez, MD, assistant professor in the Department of Medicine, Division of Hematology and Oncology, University of Illinois Chicago, emphasizes the importance of patient education and caregiver ...

Elacestrant, a selective estrogen receptor degrader, demonstrated significant improvements in progression-free survival (PFS) ...

While the Medicare Competitive Bidding Program reduced spending, it did not significantly impact supplemental oxygen use or ...

Sandra Cuellar, PharmD, from the University of Illinois Chicago, highlights the critical role of real-world data in shaping reimbursement models for oncology therapies and emphasizes the growing ...

Palliative care is quality care, and providers and health systems need to do a better job at ensuring there is equity in ...

Divya Gupta, MD, assistant professor at Feinberg School of Medicine at Northwestern University, discussed the potential of using circulating tumor DNA and minimal residual disease (MRD) assays for ...